FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/30/2026
Back to search
Official data from USPTO
FOSUN PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
05/01/2026
Trademark type
Combined
Nice classes
5, 10, 35, 42
Filing date
07/05/2024
Registration date
10/07/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/07/2025
Last transaction
05/01/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
CN
Examiner
FRUM MILONE, MARCIE R
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording FOSUNPHARMA.
Holders and representatives
Holders
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Representatives
John Alumit ALUMIT IP
Technical classification
Nice Classes
Class 5Class 10Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Antiseptics; chemico-pharmaceutical preparations for the treatment of infectious-related diseasesauto-immune and inflammatory diseasescardiovascular diseasescentral nervous system diseases and painmetabolic diseasesanti-viral diseasesoncologic diseases; anaesthetics; pharmaceutical preparations for the treatment of infectious-related diseasesauto-immune and inflammatory diseasescardiovascular diseasescentral nervous system diseases and painmetabolic diseasesanti-viral diseasesoncologic diseases; vaccines; anti-inflammatory preparations; pharmaceuticals for the treatment of infectious diseases; pharmaceutical preparations to be inhaled for the prevention and treatment of respiratory diseases and disorders; pharmaceuticals for the treatment of cancer; balsamic preparations for medical purposes; drugs for medical purposes being pharmaceutical preparations for the treatment of infectious-related diseasesauto-immune and inflammatory diseasescardiovascular diseasescentral nervous system diseases and painmetabolic diseasesanti-viral diseasesoncologic diseases; biological preparations for medical purposes being pharmaceutical preparations for the treatment of infectious-related diseasesauto-immune and inflammatory diseasescardiovascular diseasescentral nervous system diseases and painmetabolic diseasesanti-viral diseasesoncologic diseases; medicines for human purposes being pharmaceutical preparations for the treatment of infectious-related diseasesauto-immune and inflammatory diseasescardiovascular diseasescentral nervous system diseases and painmetabolic diseasesanti-viral diseasesoncologic diseases; diagnostic reagents for medical purposes; pharmaceuticals for the treatment of viral diseases; diagnostic preparations for medical purposes
Class 10
Medical apparatus and instruments for use in treating all treatable diseasesillnessesmedical conditions for humans
Class 35
Retail store or wholesale store services for medical supplies; retail store or wholesale store services for medicines; retail store or wholesale store services for pharmaceutical preparations; marketing services; sales promotion for others
Class 42
Pharmaceutical drug development; pharmaceutical research; conducting clinical trials for others
Publications
History of USPTO decisions and trademark events.
30 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/12/2026
FIMP
FINAL DISPOSITION PROCESSED
04/12/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/09/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/23/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/23/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/07/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/07/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/07/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/03/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/19/2025
PUBO
PUBLISHED FOR OPPOSITION
08/19/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/13/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/15/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
07/15/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/15/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
07/15/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/15/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/07/2025
RFNT
REFUSAL PROCESSED BY IB
04/19/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/03/2025
RFRR
REFUSAL PROCESSED BY MPU
04/03/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/28/2025
CNRT
NON-FINAL ACTION WRITTEN
02/27/2025
DOCK
ASSIGNED TO EXAMINER
12/29/2024
MAFR
APPLICATION FILING RECEIPT MAILED
10/25/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/25/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/24/2024
Continuous trademark protection
Get notified about every new filing that threatens FOSUN PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.